A randomized dose-response trial of citicoline in acute ischemic stroke patients

Neurology

Volumn 49, Issue 3, 1997, Pages 671-678

  Clark, Wayne M ^a,e   Warach, S J ^b   Pettigrew, L C ^c   Gammans, R E ^d   Sabounjian, L A ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d Interneuron Pharmaceuticals Inc   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITICOLINE; PHOSPHATIDYLCHOLINE; PLACEBO;

ADULT; ARTICLE; CELL MEMBRANE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HUMAN; LIPOGENESIS; MAJOR CLINICAL STUDY; MENTAL PERFORMANCE; NERVE CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STROKE;

EID: 0030760430     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.3.671     Document Type: Article

References (22)

1. Kennedy EP. The metabolism and function of complex liquids. Harvey Lect 1963;57:143-171.
2. Bazan NG Jr. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 1970;218:1-10.
3. Yatsu FM, Moss SA. Brain lipid changes following hypoxia. Stroke 1971;2:587-593.
4. Majewska MD, Strosznajder J, Lazarewicz J. Effect of ischemic anocia and barbiturate anesthesia on free radical oxidation of mitochondrial phospholipids. Brain Res 1976;110:547-557.
5. Trovarelli G, DeMedio GE, Dorman RV, Piccinin GL, Horrocks LA, Porcellati G. Effect of cytidine diphosphate choline (CDF-choline) on ischemia-induced alterations of brain lipid in the gerbil. Neurochem Res 1981;6:821-833.
6. Dorman RV, Dabrowiecki Z, DeMedio GE, Trovarelli G, Porcellati G, Horroks LA. Control of lipid metabolism in ischemic brain CDPamines. In: Horrocks LA, Ansell GB, Porcellati G, eds. Phospholipids in the nervous system, vol I: metabolism. New York: Raven Press, 1982:123-135.
7. Weiss GB. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Sci 1995;56:637-660.
8. Kakihana M, Fukuda N, Suno M, Nagaoka A. Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. Stroke 1988;19:217-222.
9. Dorman RV, Dabrowieki Z, Horrocks LA. Effects of CDPcholine and CDP ethanolamine on the alterations in rat brain lipid metabolism induced by global ischemia. J Neurochem 1983;40:276-279.
10. Yamamoto M, Shimizu M, Okamiya H. Pharmacological actions of a new TRH analogue, YM-14673, in rats subjected to cerebral ischemia and anoxia. Eur J Pharmacol 1990;181:207-214.
11. Boismare F, Le Poncin Lefitte M, Rapin JR. Hemodynamic, functional and biochemical effects of hypobaric hypoxia in rats treated with cytidine diphosphocholine. Presented at the Comptes rendus des seances de las Societe de Biologie. 1978; 172:651.
12. Hamdorf G, Cervos-Navarro J. Study of the effects of oral administration of CDP-choline on open-field behaviour under conditions of chronic hypoxia. Arzneim-Forsch/Drug Res 1990; 40:519-522.
13. De Medio GE, Brunett M, Dorman RV, et al. Phospholipid metabolism during central and peripheral damage and recovery in nervous tissue. Birth defects: original article series 1983;19:175-187.
14. Mykita S, Golly F, Dreyfus H, Freysz L, Massarelli R. Effect of CDP-choline on hypocampic neurons in culture. J Neurochem 1986;47:223-231.
15. Goas JY, Bastard J, Missoum A. Results after 90 days of stroke treatment with CDP-choline, concerning a double blind test. Presented at the International Symposium: Brain suffering and precursors of phospholipids; January 18, 1980; Paris.
16. Boudouresques AB, Michel B. Therapeutic conduct in light of a cerebral vascular accident and the use of CDP-choline. Presented at the International Symposium: Brain suffering and precursors of phospholipids; January 18, 1980; Paris.
17. Corso A, Arena M, Ventimiglia A, Bizzarro G, Campo G, Radalica F. CDP-choline for cerebrovascular disorders: clinical evaluation and evaluation of electrophysiological symptomology. CL Terap 1982;102:379-386.
18. Tazaki Y, Sakai F, Otomo E, et al. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke 1988;19:211-216.
19. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. MD State Med J 1965;14:61-65.
20. Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH stroke scale using video training. Stroke 1994;25:2220-2226.
21. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
22. Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 2nd ed. Littleton, MA: PSG Publishing, 1985.